Classification Term: 2146

N-acyl-alpha amino acids and derivatives (ontology term: CHEMONTID:0001189)

Compounds containing an alpha amino acid (or a derivative thereof) which bears an acyl group at its terminal nitrogen atom." []

found 82 associated metabolites at no_class-level_7 metabolite taxonomy ontology rank level.

Ancestor: Alpha amino acids and derivatives

Child Taxonomies: N-acyl-alpha amino acids

Dicloxacillin

(2S,5R,6R)-6-({[3-(2,6-dichlorophenyl)-5-methyl-1,2-oxazol-4-yl]carbonyl}amino)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid

C19H17Cl2N3O5S (469.0266)


Dicloxacillin is only found in individuals that have used or taken this drug. It is one of the penicillins which is resistant to penicillinase. [PubChem]Dicloxacillin exerts a bactericidal action against penicillin-susceptible microorganisms during the state of active multiplication. All penicillins inhibit the biosynthesis of the bacterial cell wall. By binding to specific penicillin-binding proteins (PBPs) located inside the bacterial cell wall, dicloxacillin inhibits the third and last stage of bacterial cell wall synthesis. Cell lysis is then mediated by bacterial cell wall autolytic enzymes such as autolysins; it is possible that dicloxacillin interferes with an autolysin inhibitor. J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01C - Beta-lactam antibacterials, penicillins > J01CF - Beta-lactamase resistant penicillins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D010406 - Penicillins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams C254 - Anti-Infective Agent > C258 - Antibiotic > C260 - Beta-Lactam Antibiotic

   

Cephapirin

(6R,7R)-3-[(acetyloxy)methyl]-8-oxo-7-[2-(pyridin-4-ylsulfanyl)acetamido]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid

C17H17N3O6S2 (423.0559)


Cephapirin is an injectable, first-generation cephalosporin antibiotic that has a wide spectrum of activity against gram-positive and gram-negative organisms. The bactericidal activity of cephapirin results from the inhibition of cell wall synthesis via affinity for penicillin-binding proteins (PBPs). Cephapirin is more resistant to beta-lactamases than the penicillins, and therefore is effective against staphylococci, with the exception of methicillin-resistant staphylococci. Cephapirin is FDA approved for use in food-producing animals, especially dairy cattle. Cephapirin is used for the treatment of mastitis in cows. Production for use in humans has been discontinued in the United States. It is marketed under the trade name Cefadyl. Active against gram-positive and -negative bacteria (vet. use). FDA approved for use in food producing animals, especies dairy cattle. It is used for the treatment of mastitis in cows J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01D - Other beta-lactam antibacterials > J01DB - First-generation cephalosporins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D002511 - Cephalosporins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams C254 - Anti-Infective Agent > C258 - Antibiotic > C260 - Beta-Lactam Antibiotic

   

Cefaclor

(6R,7R)-7-[(2R)-2-amino-2-phenylacetamido]-3-chloro-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid

C15H14ClN3O4S (367.0394)


Cefaclor is only found in individuals that have used or taken this drug. It is a semisynthetic, broad-spectrum antibiotic derivative of cephalexin. [PubChem]Cefaclor, like the penicillins, is a beta-lactam antibiotic. By binding to specific penicillin-binding proteins (PBPs) located inside the bacterial cell wall, it inhibits the third and last stage of bacterial cell wall synthesis. Cell lysis is then mediated by bacterial cell wall autolytic enzymes such as autolysins. It is possible that cefaclor interferes with an autolysin inhibitor. J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01D - Other beta-lactam antibacterials > J01DC - Second-generation cephalosporins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D002511 - Cephalosporins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams C254 - Anti-Infective Agent > C258 - Antibiotic > C260 - Beta-Lactam Antibiotic CONFIDENCE standard compound; EAWAG_UCHEM_ID 3069 Cefaclor is a well-absorbed orally active cephalosporin antibiotic. Cefaclor can specifically bind to specific for penicillin-binding protein 3 (PBP3). Cefaclor can be used for the research of depression and kinds of infections caused by bacteria, such as respiratory tract infections, bacterial bronchitis, pharyngitis and skin infections[1][2][3][4].

   

Cephalosporin C

(6R,7R)-3-[(acetyloxy)methyl]-7-{[(5R)-5-amino-5-carboxy-1-hydroxypentylidene]amino}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid

C16H21N3O8S (415.1049)


Cephalosporin C is an antibiotic of the cephalosporin class. It was isolated from fungi of the genus Acremonium and first characterized in 1961. Although not a very active antibiotic itself, synthetic analogs of cephalosporin C, such as cefalotin, became some of the first marketed cephalosporin antibiotic drugs. (Wikipedia) D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D002511 - Cephalosporins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams

   

Cefradine

(6R,7R)-7-{[(2R)-2-amino-2-cyclohexa-1,4-dien-1-ylacetyl]amino}-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid

C16H19N3O4S (349.1096)


Cefradine is only found in individuals that have used or taken this drug. It is a semi-synthetic cephalosporin antibiotic.Cefradine is a first generation cephalosporin antibiotic with a spectrum of activity similar to Cefalexin. Cefradine, like the penicillins, is a beta-lactam antibiotic. By binding to specific penicillin-binding proteins (PBPs) located inside the bacterial cell wall, it inhibits the third and last stage of bacterial cell wall synthesis. Cell lysis is then mediated by bacterial cell wall autolytic enzymes such as autolysins; it is possible that Cefradine interferes with an autolysin inhibitor. J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01D - Other beta-lactam antibacterials > J01DB - First-generation cephalosporins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D002511 - Cephalosporins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams C254 - Anti-Infective Agent > C258 - Antibiotic > C260 - Beta-Lactam Antibiotic

   

Latamoxef

(6R,7R)-7-[2-carboxy-2-(4-hydroxyphenyl)acetamido]-7-methoxy-3-{[(1-methyl-1H-1,2,3,4-tetrazol-5-yl)sulfanyl]methyl}-8-oxo-5-oxa-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid

C20H20N6O9S (520.1012)


Broad- spectrum beta-lactam antibiotic similar in structure to the cephalosporins except for the substitution of an oxaazabicyclo moiety for the thiaazabicyclo moiety of certain cephalosporins. It has been proposed especially for the meningitides because it passes the blood-brain barrier and for anaerobic infections. [PubChem] J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01D - Other beta-lactam antibacterials > J01DD - Third-generation cephalosporins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams C254 - Anti-Infective Agent > C258 - Antibiotic > C260 - Beta-Lactam Antibiotic

   

Cefmetazole

(6R,7S)-7-{2-[(cyanomethyl)sulfanyl]acetamido}-7-methoxy-3-{[(1-methyl-1H-1,2,3,4-tetrazol-5-yl)sulfanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid

C15H17N7O5S3 (471.0453)


Cefmetazole is only found in individuals that have used or taken this drug. It is a semisynthetic cephamycin antibiotic with a broad spectrum of activity against both gram-positive and gram-negative microorganisms. It has a high rate of efficacy in many types of infection and to date no severe side effects have been noted. [PubChem]The bactericidal activity of cefmetazole results from the inhibition of cell wall synthesis via affinity for penicillin-binding proteins (PBPs). J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01D - Other beta-lactam antibacterials > J01DC - Second-generation cephalosporins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D002511 - Cephalosporins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D002513 - Cephamycins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams C254 - Anti-Infective Agent > C258 - Antibiotic > C260 - Beta-Lactam Antibiotic

   

Small bacteriocin

(7E)-3-Hydroxy-N-(2-oxooxolan-3-yl)tetradec-7-enimidate

C18H31NO4 (325.2253)


Bacteriocin. Small bacteriocin is produced by Rhizobium leguminosarum. Bacteriocin. Production by Rhizobium leguminosarum.

   

Septacidin

N-({[2-(1,2-dihydroxyethyl)-4,5-dihydroxy-6-[(9H-purin-6-yl)amino]oxan-3-yl]-C-hydroxycarbonimidoyl}methyl)-14-methylpentadecanimidate

C30H51N7O7 (621.385)


   

AK toxin I

(2E,4Z,6E)-8-[(2-acetamido-3-phenylbutanoyl)oxy]-8-(2-methyloxiran-2-yl)octa-2,4,6-trienoic acid

C23H27NO6 (413.1838)


AK toxin I is produced by Alternaria alternata Japanese pear pathotyp

   

Methyl hippurate

methyl 2-(phenylformamido)acetate

C10H11NO3 (193.0739)


Methylhippuric acid is an acyl glycine. Acyl glycines are normally minor metabolites of fatty acids. However, the excretion of certain acyl glycines is increased in several inborn errors of metabolism. In certain cases the measurement of these metabolites in body fluids can be used to diagnose disorders associated with mitochondrial fatty acid beta-oxidation. Acyl glycines are produced through the action of glycine N-acyltransferase (EC 2.3.1.13) which is an enzyme that catalyzes the chemical reaction: acyl-CoA + glycine < -- > CoA + N-acylglycine. Methylhippuric acid is a metabolite of xylene which is an aromatic hydrocarbon widely used as a solvant. The amount of methylhippuric acid can be measured in urine of workers exposed to xylene (PMID 8689499). Methylhippuric acid is an acyl glycine. Acyl glycines are normally minor metabolites of fatty acids. However, the excretion of certain acyl glycines is increased in several inborn errors of metabolism. In certain cases the measurement of these metabolites in body fluids can be used to diagnose disorders associated with mitochondrial fatty acid beta-oxidation. Acyl glycines are produced through the action of glycine N-acyltransferase (EC 2.3.1.13) which is an enzyme that catalyzes the chemical reaction:

   

N-[(Ethoxycarbonyl)methyl)-p-menthane-3-carboxamide

N-(2-Ethoxy-2-oxoethyl)-5-methyl-2-(propan-2-yl)cyclohexane-1-carboximidate

C15H27NO3 (269.1991)


N-[(Ethoxycarbonyl)methyl)-p-menthane-3-carboxamide is used as a food additive [EAFUS] ("EAFUS: Everything Added to Food in the United States. [http://www.eafus.com/]")

   

Pseudomonine

2-Hydroxy-N-{2-[2-(1H-imidazol-5-yl)ethyl]-5-methyl-3-oxo-1,2-oxazolidin-4-yl}benzene-1-carboximidate

C16H18N4O4 (330.1328)


Pseudomonine is found in fishes. Pseudomonine is an alkaloid from cultures of Pseudomonas fluorescens AH2 isolated from spoiled Nile perch from Lake Victoria. Alkaloid from cultures of Pseudomonas fluorescens AH2 isolated from spoiled Nile perch from Lake Victoria. Pseudomonine is found in fishes.

   

O-Desmethyl-lacosamide

(2R)-N-benzyl-2-acetamido-3-hydroxypropanamide

C12H16N2O3 (236.1161)


O-Desmethyl-lacosamide is a metabolite of lacosamide. Lacosamide (formerly known as erlosamide) is a medication developed by UCB for the adjunctive treatment of partial-onset seizures and diabetic neuropathic pain marketed under the trade name Vimpat. The U.S. Food and Drug Administration accepted UCBs New Drug Application for lacosamide as of November 29, 2007, beginning the approval process for the drug. (Wikipedia)

   

gamma-Glutamyl-2-aminobutyrate

2-azaniumyl-4-[(1-carboxypropyl)carbamoyl]butanoate

C9H15N2O5- (231.0981)


   

Actinonin

2-[(Dihydroxycarbonimidoyl)methyl]-N-{1-[2-(hydroxymethyl)pyrrolidin-1-yl]-3-methyl-1-oxobutan-2-yl}heptanimidate

C19H35N3O5 (385.2577)


   

Deoxyspergualin

N-[({4-[(3-aminopropyl)amino]butyl}-C-hydroxycarbonimidoyl)(hydroxy)methyl]-7-carbamimidamidoheptanimidate

C17H37N7O3 (387.2958)


   

(3R)-3-Hydroxy-N-[(3S)-2-oxooxolan-3-yl]butanamide

3-hydroxy-N-(2-oxooxolan-3-yl)butanamide

C8H13NO4 (187.0845)


   

Adb-chminaca, (+/-)-

N-(1-Amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide

C21H30N4O2 (370.2369)


   

N-(2-Amino-2-oxoethyl)-2-methylprop-2-enamide

N-(carbamoylmethyl)-2-methylprop-2-enamide

C6H10N2O2 (142.0742)


   

3-Phenylacetylamino-2,6-piperidinedione

N-(2,6-dioxopiperidin-3-yl)-2-phenylacetamide

C13H14N2O3 (246.1004)


   

L-Cysteine, N-acetyl-, ethyl ester

N-(1-Ethoxy-1-oxo-3-sulphanylpropan-2-yl)ethanimidic acid

C7H13NO3S (191.0616)


   

2-(1-(5-Fluoropentyl)-1H-indazole-3-ylcarbonylamino)-3-methylbutanoic acid methyl ester

methyl 2-{[1-(5-fluoropentyl)-1H-indazol-3-yl]formamido}-3-methylbutanoate

C19H26FN3O3 (363.1958)


   

5-Fluoro-adb, (+/-)-

N-((1-(5-Fluoropentyl)-1H-indazol-3-yl)carbonyl)-3-methyl-D-valine methyl ester

C20H28FN3O3 (377.2115)


   

N-[(3s)-2-Oxotetrahydrofuran-3-Yl]butanamide

N-(2-oxooxolan-3-yl)butanimidic acid

C8H13NO3 (171.0895)


   

AB-Chminaca

N-(1-(Aminocarbonyl)-2-methylpropyl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide

C20H28N4O2 (356.2212)


   

AB-Fubinaca

2-({1-[(4-fluorophenyl)methyl]-1H-indazol-3-yl}formamido)-3-methylbutanamide

C20H21FN4O2 (368.1648)


   

AB-Pinaca

3-methyl-2-[(1-pentyl-1H-indazol-3-yl)formamido]butanamide

C18H26N4O2 (330.2056)


   

Amtolmetin guacil

2-methoxyphenyl 2-{2-[1-methyl-5-(4-methylbenzoyl)-1H-pyrrol-2-yl]acetamido}acetate

C24H24N2O5 (420.1685)


C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D000700 - Analgesics D000893 - Anti-Inflammatory Agents D018501 - Antirheumatic Agents

   

Analogue A

5-Chloro-N-[3-(2-chlorophenyl)-1-(4-hydroxypiperidin-1-yl)-1-oxopropan-2-yl]-1H-indole-2-carboximidate

C23H23Cl2N3O3 (459.1116)


   

Benin

N-(2-Ethoxy-2-oxoethyl)-5-(9H-purin-6-ylsulphanyl)pentanimidic acid

C14H19N5O3S (337.1209)


   

Benzylpenicilloyl G

2-{[(5-carboxypentyl)-C-hydroxycarbonimidoyl][(1-hydroxy-2-phenylethylidene)amino]methyl}-5,5-dimethyl-1,3-thiazolidine-4-carboxylate

C22H31N3O6S (465.1933)


D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D010406 - Penicillins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams

   

Ceftazidime anhydrous

1-({7-[2-(2-amino-1,3-thiazol-4-yl)-2-[(1-carboxy-1-methylethoxy)imino]acetamido]-2-carboxylato-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-en-3-yl}methyl)pyridin-1-ium

C22H22N6O7S2 (546.0991)


   

Ceftolozane

5-amino-2-({7-[2-(5-amino-1,2,4-thiadiazol-3-yl)-2-[(1-carboxy-1-methylethoxy)imino]acetamido]-2-carboxy-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-en-3-yl}methyl)-4-{[(2-aminoethyl)carbamoyl]amino}-1-methyl-1H-pyrazol-2-ium

C23H30N12O8S2 (666.1751)


   

N-[(3R)-1-(2-Fluorophenyl)-4-oxo-3,4,6,7-tetrahydro[1,4]diazepino[6,7,1-hi]indol-3-yl]-1H-indole-2-carboxamide

N-[9-(2-fluorophenyl)-12-oxo-1,10-diazatricyclo[6.4.1.0^{4,13}]trideca-4,6,8(13),9-tetraen-11-yl]-1H-indole-2-carboxamide

C26H19FN4O2 (438.1492)


   

CI-1044

N-{6-amino-12-oxo-9-phenyl-1,10-diazatricyclo[6.4.1.0^{4,13}]trideca-4(13),5,7,9-tetraen-11-yl}pyridine-3-carboxamide

C23H19N5O2 (397.1539)


   

Citiolone

N-(2-oxothiolan-3-yl)ethanimidic acid

C6H9NO2S (159.0354)


A - Alimentary tract and metabolism > A05 - Bile and liver therapy > A05B - Liver therapy, lipotropics > A05BA - Liver therapy C78273 - Agent Affecting Respiratory System > C29767 - Expectorant C26170 - Protective Agent > C2081 - Hepatoprotective Agent

   

(S)-4-[(S)-2-((S)-1-Formyl-4-guanidino-butylcarbamoyl)-pyrrolidin-1-yl]-4-oxo-3-(2-propyl-pentanoylamino)-butyric acid methyl ester

N-(5-Carbamimidamido-1-oxopentan-2-yl)-1-{2-[(1-hydroxy-2-propylpentylidene)amino]-4-methoxy-4-oxobutanoyl}pyrrolidine-2-carboximidate

C24H42N6O6 (510.3166)


   

Daglutril

2-(3-{1-[3-ethoxy-3-oxo-2-(2-phenylethyl)propyl]cyclopentaneamido}-2-oxo-2,3,4,5-tetrahydro-1H-1-benzazepin-1-yl)acetic acid

C31H38N2O6 (534.273)


   

Dirlotapide

N-{2-[Benzyl(methyl)amino]-2-oxo-1-phenylethyl}-1-methyl-5-{[4-(trifluoromethyl)[1,1-biphenyl]-2-carbonyl]amino}-1H-indole-2-carboxamide

C40H33F3N4O3 (674.2505)


   

Dimethyloxalylglycine

methyl [(2-methoxy-2-oxoethyl)carbamoyl]formate

C6H9NO5 (175.0481)


   

Ecadotril

benzyl 2-{2-[(acetylsulfanyl)methyl]-3-phenylpropanamido}acetate

C21H23NO4S (385.1348)


   

Erdosteine

2-({[(2-oxothiolan-3-yl)-C-hydroxycarbonimidoyl]methyl}sulphanyl)acetic acid

C8H11NO4S2 (249.0129)


R - Respiratory system > R05 - Cough and cold preparations > R05C - Expectorants, excl. combinations with cough suppressants > R05CB - Mucolytics C78273 - Agent Affecting Respiratory System > C74536 - Mucolytic Agent D019141 - Respiratory System Agents > D005100 - Expectorants

   

Ethyl N2-acetyl-L-argininate

N-(5-Carbamimidamido-1-ethoxy-1-oxopentan-2-yl)ethanimidate

C10H20N4O3 (244.1535)


   

Fasidotril

3-(Acetylsulphanyl)-2-[(2H-1,3-benzodioxol-5-yl)methyl]-N-[1-(benzyloxy)-1-oxopropan-2-yl]propanimidic acid

C23H25NO6S (443.1403)


   

(E)-3-(6-Acetamidopyridin-3-yl)-N-[2-[2,4-dichloro-N-methyl-3-[(2-methylquinolin-8-yl)oxymethyl]anilino]-2-oxoethyl]prop-2-enamide

N-{[(2,4-dichloro-3-{[(2-methylquinolin-8-yl)oxy]methyl}phenyl)(methyl)carbamoyl]methyl}-3-(6-acetamidopyridin-3-yl)prop-2-enamide

C30H27Cl2N5O4 (591.144)


   

Flomoxef

7-({2-[(difluoromethyl)sulphanyl]-1-hydroxyethylidene}amino)-3-({[1-(2-hydroxyethyl)-1H-1,2,3,4-tetrazol-5-yl]sulphanyl}methyl)-7-methoxy-8-oxo-5-oxa-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid

C15H18F2N6O7S2 (496.0646)


   

Fuzlocillin

6-[(2-{[(3-{[(furan-2-yl)methylidene]amino}-2-oxoimidazolidin-1-yl)(hydroxy)methylidene]amino}-1-hydroxy-2-(4-hydroxyphenyl)ethylidene)amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate

C25H26N6O8S (570.1533)


   

2-Chloro-N-[1-[(2R)-2,3-dihydroxypropyl]-2-oxo-3,4-dihydroquinolin-3-yl]-6H-thieno[2,3-b]pyrrole-5-carboxamide

2-Chloro-N-[1-[(2R)-2,3-dihydroxypropyl]-1,2,3,4-tetrahydro-2-oxo-3-quinolinyl]-6H-thieno[2,3-b]pyrrole-5-carboxamide

C19H18ClN3O4S (419.0706)


   
   

IL-1R Antagonist

N-[3-methyl-1-oxo-1-(pyrrolidin-1-yl)butan-2-yl]-3-phenylpropanamide

C18H26N2O2 (302.1994)


   

Ilomastat

N-hydroxy-N-[3-(1H-indol-3-yl)-1-(methylamino)-1-oxopropan-2-yl]-2-(2-methylpropyl)butanediamide

C20H28N4O4 (388.211)


   

(2E,4E)-N-[2-[[(2R,3R,4R,5R,6S)-2-(1,2-Dihydroxyethyl)-4,5-dihydroxy-6-(7H-purin-6-ylamino)oxan-3-yl]amino]-2-oxoethyl]tetradeca-2,4-dienamide

N-({[2-(1,2-dihydroxyethyl)-4,5-dihydroxy-6-[(7H-purin-6-yl)amino]oxan-3-yl]carbamoyl}methyl)tetradeca-2,4-dienamide

C28H43N7O7 (589.3224)


   

(2S)-2-[[2-[(2S,3S)-2-[[(2R)-2-Amino-3-mercaptopropyl]amino]-3-methylpentoxy]-1-oxo-3-phenylpropyl]amino]-4-methylsulfonylbutanoic acid propan-2-yl ester

(2S)-2-[[2-[(2S,3S)-2-[[(2R)-2-Amino-3-mercaptopropyl]amino]-3-methylpentoxy]-1-oxo-3-phenylpropyl]amino]-4-methylsulphonylbutanoic acid propan-2-yl ester

C26H45N3O6S2 (559.275)


   

L-Prolinamide, 5-oxo-L-prolyl-L-norvalyl-

N-[1-(2-carbamoylpyrrolidin-1-yl)-1-oxopentan-2-yl]-5-oxopyrrolidine-2-carboxamide

C15H24N4O4 (324.1797)


   

Lacosamide

N-benzyl-2-[(1-hydroxyethylidene)amino]-3-methoxypropanimidic acid

C13H18N2O3 (250.1317)


   

Lotilaner

2-({3-methyl-5-[5-(3,4,5-trichlorophenyl)-5-(trifluoromethyl)-4,5-dihydro-1,2-oxazol-3-yl]thiophen-2-yl}formamido)-N-(2,2,2-trifluoroethyl)acetamide

C20H14Cl3F6N3O3S (594.9726)


   

(4S,7S,12Br)-6-oxo-7-[[(2S)-3-phenyl-2-sulfanylpropanoyl]amino]-2,3,4,7,8,12b-hexahydro-1H-pyrido[2,1-a][2]benzazepine-4-carboxylic acid

(4S,7S,12BR)-6-oxo-7-[[(2S)-3-Phenyl-2-sulphanylpropanoyl]amino]-2,3,4,7,8,12b-hexahydro-1H-pyrido[2,1-a][2]benzazepine-4-carboxylic acid

C24H26N2O4S (438.1613)


   

(4S,7S,12Br)-7-[[(2R)-2-acetylsulfanyl-3-phenylpropanoyl]amino]-6-oxo-2,3,4,7,8,12b-hexahydro-1H-pyrido[2,1-a][2]benzazepine-4-carboxylic acid

(4S,7S,12BR)-7-[[(2R)-2-Acetylsulphanyl-3-phenylpropanoyl]amino]-6-oxo-2,3,4,7,8,12b-hexahydro-1H-pyrido[2,1-a][2]benzazepine-4-carboxylic acid

C26H28N2O5S (480.1719)


   

Midesteine

(2-(3-Thiophencarboxythio)-N-(dihydro-2(3H)-thiophenone-3-I))propionamide

C12H13NO3S3 (315.0058)


C78273 - Agent Affecting Respiratory System > C74536 - Mucolytic Agent

   

Methyl (1-(4-fluorobenzyl)-1H-indazole-3-carbonyl)-L-valinate

methyl 2-({1-[(4-fluorophenyl)methyl]-1H-indazol-3-yl}formamido)-3-methylbutanoate

C21H22FN3O3 (383.1645)


   

N-Acetylcysteinamide

2-acetamido-3-sulfanylpropanamide

C5H10N2O2S (162.0463)


   

N-Octanoyl-L-homoserine lactone

(S)-2-(octanoylamino)-4-methyl-4-oxobutanoic acid lactone

C12H21NO3 (227.1521)


N-(2-oxooxolan-3-yl)octanimidic acid belongs to the class of organic compounds known as n-acyl-alpha amino acids and derivatives. N-acyl-alpha amino acids and derivatives are compounds containing an alpha amino acid (or a derivative thereof) which bears an acyl group at its terminal nitrogen atom. Based on a literature review very few articles have been published on N-(2-oxooxolan-3-yl)octanimidic acid. This compound has been identified in human blood as reported by (PMID: 31557052 ). Octanoyl-l-homoserine lactone is not a naturally occurring metabolite and is only found in those individuals exposed to this compound or its derivatives. Technically Octanoyl-L-homoserine lactone is part of the human exposome. The exposome can be defined as the collection of all the exposures of an individual in a lifetime and how those exposures relate to health. An individual's exposure begins before birth and includes insults from environmental and occupational sources. N-Octanoyl-L-homoserine lactone (OHL) is an important signaling molecule used by many bacteria in a process known as quorum sensing (QS). This process allows bacteria to communicate with each other and coordinate their behavior based on population density. Here are some of the key biological functions of OHL: 1. **Quorum Sensing Signaling**: As a quorum sensing autoinducer, OHL plays a critical role in regulating gene expression in response to changes in cell population density. When the concentration of OHL reaches a certain threshold, it binds to specific receptors, triggering a cascade of cellular responses. 2. **Regulation of Virulence Factors**: In many pathogenic bacteria, OHL is involved in the regulation of virulence factors, which are molecules or proteins that enhance the bacterium's ability to cause disease. By controlling the expression of these factors, OHL can significantly influence the pathogenicity of the bacteria. 3. **Biofilm Formation and Regulation**: Biofilms are structured communities of bacteria that are often encased in a self-produced matrix. OHL can play a role in the initiation, development, and maintenance of biofilms. Biofilms are associated with increased resistance to antibiotics and immune system evasion, making them a significant concern in medical and industrial settings. 4. **Cell Motility and Swarm Behavior**: In some bacteria, OHL is involved in regulating cell motility, which includes the ability to move towards or away from certain stimuli. This can affect the bacteria's ability to colonize new areas or to form biofilms. 5. **Symbiotic Interactions**: OHL is not only important in pathogenic bacteria but also in beneficial interactions, such as those found in nitrogen-fixing bacteria or in symbiotic relationships with plants and animals. Understanding the role of OHL and other quorum sensing molecules is crucial for developing new strategies to control bacterial infections, manage biofilm-related issues, and potentially exploit these systems for beneficial purposes.

   

1-Oxononan-4-yl (2R)-2-acetamido-3-sulfanylpropanoate

N-{1-oxo-1-[(1-oxononan-4-yl)oxy]-3-sulphanylpropan-2-yl}ethanimidic acid

C14H25NO4S (303.1504)


   

Paracetamol mercapturate

4-acetamidophenyl 2-acetamido-3-sulfanylpropanoate

C13H16N2O4S (296.0831)


   

N-(2-Benzyl-3-((2-amino-4-methylpentyl)dithio)-1-oxopropyl)glycine benzyl ester

3-[(2-Amino-4-methylpentyl)disulphanyl]-2-benzyl-N-[2-(benzyloxy)-2-oxoethyl]propanimidic acid

C25H34N2O3S2 (474.2011)


   

Penicillin F

6-[(1-Hydroxyhex-3-en-1-ylidene)amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate

C14H20N2O4S (312.1144)


   

(R)-N1-((S)-3,3-Dimethyl-1-(methylamino)-1-oxobutan-2-yl)-N4-hydroxy-2-isobutylsuccinamide

2-[(Dihydroxycarbonimidoyl)methyl]-N-[2,2-dimethyl-1-(methyl-C-hydroxycarbonimidoyl)propyl]-4-methylpentanimidate

C15H29N3O4 (315.2158)


   

[4-((1Z)-2-(Acetylamino)-3-{[1-(1,1'-biphenyl-4-ylmethyl)-2-oxoazepan-3-YL]amino}-3-oxoprop-1-enyl)-2-formylphenyl]acetic acid

2-[4-(2-{[1-({[1,1-biphenyl]-4-yl}methyl)-2-oxoazepan-3-yl]-C-hydroxycarbonimidoyl}-2-[(1-hydroxyethylidene)amino]eth-1-en-1-yl)-2-formylphenyl]acetate

C33H33N3O6 (567.2369)


   

N-Acetyl-N-[1-(1,1'-biphenyl-4-ylmethyl)-2-oxoazepan-3-YL]-3,4-diphosphonophenylalaninamide

N-[1-({[1,1-biphenyl]-4-yl}methyl)-2-oxoazepan-3-yl]-3-(3,4-diphosphonophenyl)-2-[(1-hydroxyethylidene)amino]propanimidate

C30H35N3O9P2 (643.1848)


   

Semagacestat

2-Hydroxy-3-methyl-N-{1-[(3-methyl-2-oxo-2,3,4,5-tetrahydro-1H-3-benzazepin-1-yl)-C-hydroxycarbonimidoyl]ethyl}butanimidate

C19H27N3O4 (361.2001)


   

Spergualin

N-[({4-[(3-aminopropyl)amino]butyl}-C-hydroxycarbonimidoyl)(hydroxy)methyl]-7-carbamimidamido-3-hydroxyheptanimidate

C17H37N7O4 (403.2907)


   

N-(Tetrahydro-2-oxo-3-thienyl)-3-pyridinecarboxamide

N-(2-oxothiolan-3-yl)pyridine-3-carboxamide

C10H10N2O2S (222.0463)


   

Tarazepide

N-(1-methyl-2-oxo-5-phenyl-2,3-dihydro-1H-1,4-benzodiazepin-3-yl)-1-azatricyclo[6.3.1.0^{4,12}]dodeca-2,4(12),5,7-tetraene-2-carboxamide

C28H24N4O2 (448.1899)


   

Nitrocefin

3-[2-(2,4-dinitrophenyl)ethenyl]-8-oxo-7-[2-(thiophen-2-yl)acetamido]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid

C21H16N4O8S2 (516.041)


   

Brisoral

7-{[2-amino-1-hydroxy-2-(4-hydroxyphenyl)ethylidene]amino}-8-oxo-3-(prop-1-en-1-yl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate

C18H19N3O5S (389.1045)


   

N-[3,3-Dimethyl-1-(methylamino)-1-oxobutan-2-yl]-N'-hydroxy-3-(hydroxymethyl)-2-(4-methoxyphenyl)butanediamide

3-(Dihydroxycarbonimidoyl)-N-[2,2-dimethyl-1-(methyl-C-hydroxycarbonimidoyl)propyl]-4-hydroxy-2-(4-methoxyphenyl)butanimidate

C19H29N3O6 (395.2056)


   

S-Ethyl 2-acetylaminoethanethioate

N-[2-(Ethylsulphanyl)-2-oxoethyl]ethanimidic acid

C6H11NO2S (161.051)


It is used as a food additive .

   

GMP-N-epsilon-(N-alpha-acetyl lysine methyl ester) 5'-phosphoramidate

N-{6-[({[3,4-dihydroxy-5-(6-hydroxy-2-imino-3,9-dihydro-2H-purin-9-yl)oxolan-2-yl]methoxy}(hydroxy)phosphoryl)amino]-1-methoxy-1-oxohexan-2-yl}ethanecarboximidic acid

C19H29N7O10P (546.1713)


Gmp-n-epsilon-(n-alpha-acetyl lysine methyl ester) 5-phosphoramidate is slightly soluble (in water) and a moderately acidic compound (based on its pKa). Gmp-n-epsilon-(n-alpha-acetyl lysine methyl ester) 5-phosphoramidate can be found in a number of food items such as thistle, wax apple, okra, and hedge mustard, which makes gmp-n-epsilon-(n-alpha-acetyl lysine methyl ester) 5-phosphoramidate a potential biomarker for the consumption of these food products.

   

N-methylanthraniloyl-CoA

(2R)-4-({[({[(2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-4-hydroxy-3-(phosphonatooxy)oxolan-2-yl]methoxy}(hydroxy)phosphoryl)oxy](hydroxy)phosphoryl}oxy)-2-hydroxy-3,3-dimethyl-N-[2-({2-[2-(methylamino)benzoylsulfanyl]ethyl}carboximidato)ethyl]butanecarboximidate

C29H39N8O17P3S (896.1367)


N-methylanthraniloyl-coa, also known as S-(2-aminobenzoyl)-coa(4-), is a member of the class of compounds known as acyl coas. Acyl coas are organic compounds containing a coenzyme A substructure linked to an acyl chain. N-methylanthraniloyl-coa is slightly soluble (in water) and an extremely strong acidic compound (based on its pKa). N-methylanthraniloyl-coa can be found in a number of food items such as rocket salad, cascade huckleberry, wild leek, and grapefruit, which makes N-methylanthraniloyl-coa a potential biomarker for the consumption of these food products.

   

N-alpha-acetyl lysine methyl ester

(5-acetamido-6-methoxy-6-oxohexyl)azaniumyl

C9H16N2O3 (200.1161)


N-alpha-acetyl lysine methyl ester is slightly soluble (in water) and a very weakly acidic compound (based on its pKa). N-alpha-acetyl lysine methyl ester can be found in a number of food items such as sesbania flower, rambutan, cloud ear fungus, and banana, which makes N-alpha-acetyl lysine methyl ester a potential biomarker for the consumption of these food products.

   

Ubrogepant

1,2,5,7-Tetrahydro-N-((3S,5S,6R)-6-methyl-2-oxo-5-phenyl-1-(2,2,2-trifluoroethyl)-3-piperidinyl)-2-oxo-, (6S)- spiro(6H-cyclopenta(b)pyridine-6,3-(3H)pyrrolo(2,3-b)pyridine)-3-carboxamide

C29H26F3N5O3 (549.1988)


N - Nervous system > N02 - Analgesics > N02C - Antimigraine preparations > N02CD - Calcitonin gene-related peptide (cgrp) antagonists C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent